Search Results - "Preijers, F"

Refine Results
  1. 1

    Genetic diversity within leukemia-associated immunophenotype-defined subclones in AML by Tiso, F., Koorenhof-Scheele, T. N., Huys, E., Martens, J. H. A., de Graaf, A. O., van der Reijden, B. A., Langemeijer, S. M. C., Preijers, F. W. M. B., Kroeze, L. I., Jansen, J. H.

    Published in Annals of hematology (01-03-2022)
    “…Acute myeloid leukemia (AML) is a highly heterogeneous disease showing dynamic clonal evolution patterns over time. Various subclones may be present…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Rapamycin and MPA, But Not CsA, Impair Human NK Cell Cytotoxicity Due to Differential Effects on NK Cell Phenotype by Eissens, D. N., Van Der Meer, A., Van Cranenbroek, B., Preijers, F. W. M. B., Joosten, I.

    Published in American journal of transplantation (01-09-2010)
    “…Cyclosporin A (CsA), rapamycin (Rapa) and mycophenolic acid (MPA) are frequently used for GVHD prophylaxis and treatment after allogeneic stem cell…”
    Get full text
    Journal Article
  4. 4

    Long-term follow-up results after autologous haematopoietic stem cell transplantation for severe systemic sclerosis by Vonk, M C, Marjanovic, Z, van den Hoogen, F H J, Zohar, S, Schattenberg, A V M B, Fibbe, W E, Larghero, J, Gluckman, E, Preijers, F W M B, van Dijk, A P J, Bax, J J, Roblot, P, van Riel, P L C M, van Laar, J M, Farge, D

    Published in Annals of the rheumatic diseases (01-01-2008)
    “…Systemic sclerosis (SSc) is a generalised autoimmune disease, causing morbidity and a reduced life expectancy, especially in patients with rapidly progressive…”
    Get more information
    Journal Article
  5. 5
  6. 6

    A pilot study on the immunogenicity of dendritic cell vaccination during adjuvant oxaliplatin capecitabine chemotherapy in colon cancer patients by Lesterhuis, W J, de Vries, I J M, Aarntzen, E A, de Boer, A, Scharenborg, N M, van de Rakt, M, van Spronsen, D-J, Preijers, F W, Figdor, C G, Adema, G J, Punt, C J A

    Published in British journal of cancer (26-10-2010)
    “…Background: Dendritic cell (DC) vaccination has been shown to induce anti-tumour immune responses in cancer patients, but so far its clinical efficacy is…”
    Get full text
    Journal Article
  7. 7

    Establishment of harmonization in immunophenotyping: A comparative study of a standardized one‐tube lymphocyte‐screening panel by Preijers, F. W. M. B., Huys, E., Favre, C., Moshaver, B.

    Published in Cytometry. Part B, Clinical cytometry (01-11-2014)
    “…Background Multiparameter flow cytometry has been increasingly used in the identification and characterization of leukemia and lymphoma. However, due to…”
    Get full text
    Journal Article
  8. 8

    Adult metachromatic leukodystrophy treated by allo-SCT and a review of the literature by de Hosson, L D, van de Warrenburg, B P C, Preijers, F W M B, Blijlevens, N M A, van der Reijden, B A, Kremer, H P H, Lefeber, D J, Allebes, W A, Al-Ali, H, Niederwieser, D W, Schaap, N P M, Schattenberg, A V M B

    Published in Bone marrow transplantation (Basingstoke) (01-08-2011)
    “…Five patients with adult-onset metachromatic leukodystrophy (MLD) underwent allo-SCT. Conditioning was reduced in intensity and grafts were obtained from…”
    Get full text
    Journal Article
  9. 9

    Defining consensus leukemia-associated immunophenotypes for detection of minimal residual disease in acute myeloid leukemia in a multicenter setting by Feller, N, van der Velden, V H J, Brooimans, R A, Boeckx, N, Preijers, F, Kelder, A, de Greef, I, Westra, G, te Marvelde, J G, Aerts, P, Wind, H, Leenders, M, Gratama, J W, Schuurhuis, G J

    Published in Blood cancer journal (New York) (02-08-2013)
    “…Flow-cytometric detection of minimal residual disease (MRD) has proven in several single-institute studies to have an independent prognostic impact. We studied…”
    Get full text
    Journal Article
  10. 10

    Flow cytometric pattern recognition of lymph node biopsies with lymphomas that lack lineage characteristics by Hebeda, K., Preijers, F.

    “…Summary Although immunophenotyping (IPT) using flow cytometry is a routine technique that is applied in many laboratories as a diagnostic tool for…”
    Get full text
    Journal Article
  11. 11

    CD3 CD19 -depleted grafts in HLA-matched allogeneic peripheral blood stem cell transplantation lead to early NK cell cytolytic responses and reduced inhibitory activity of NKG2A by Eissens, D N, Schaap, N P M, Preijers, F W M B, Dolstra, H, van Cranenbroek, B, Schattenberg, A V M, Joosten, I, van der Meer, A

    Published in Leukemia (01-03-2010)
    “…Natural killer (NK) cells have an important function in the anti-tumor response early after stem cell transplantation (SCT). As part of a prospective…”
    Get full text
    Journal Article
  12. 12

    Functionally active NKG2A-expressing natural killer cells are elevated in rheumatoid arthritis patients compared to psoriatic arthritis patients and healthy donors by van Bijnen, S T A, Cossu, M, Roeven, M W H, Jansen, T L, Preijers, F, Spanholtz, J, Dolstra, H, Radstake, T R D J

    Published in Clinical and experimental rheumatology (01-11-2015)
    “…Natural killer cell receptors (NKR) have been implicated in rheumatoid (RA) and psoriatic arthritis (PsA) pathogenesis. To gain more insight into their role,…”
    Get full text
    Journal Article
  13. 13

    Evaluation of ‘out-of-specification’ CliniMACS CD34-selection procedures of hematopoietic progenitor cell-apheresis products by Braakman, E., PhD, Schuurhuis, G.J, Preijers, F.W.M.B, Voermans, C, Theunissen, K, van Riet, I, Fibbe, W.E, Slaper-Cortenbach, I

    Published in Cytotherapy (Oxford, England) (2008)
    “…Background Immunomagnetic selection of CD34+ hematopoietic progenitor cells (HPC) using CliniMACS CD34 selection technology is widely used to provide…”
    Get full text
    Journal Article
  14. 14

    Induction of graft-versus-leukemia to prevent relapse after partially lymphocyte-depleted allogeneic bone marrow transplantation by pre-emptive donor leukocyte infusions by SCHAAP, N, SCHATTENBERG, A, BÄR, B, PREIJERS, F, VAN DE WIEL VAN KEMENADE, E, DE WITTE, T

    Published in Leukemia (01-09-2001)
    “…In this prospective study we analyzed pre-emptive donor leukocyte infusions (DLI) in 82 consecutive patients transplanted with partially T cell-depleted grafts…”
    Get full text
    Journal Article
  15. 15

    Long-term follow-up of persisting mixed chimerism after partially T cell-depleted allogeneic stem cell transplantation by SCHAAP, N, SCHATTENBERG, A, DE WITTE, T, MENSINK, E, PREIJERS, F, HILLEGERS, M, KNOPS, R, PENNINGS, A, BOEZEMAN, J, GEURTS VAN KESSEL, A, DE PAUW, B

    Published in Leukemia (2002)
    “…Using red cell phenotyping (RCP) and/or cytogenetics (CYT) we identified 19 patients with persisting mixed chimerism (MC) among 231 patients transplanted with…”
    Get full text
    Journal Article
  16. 16

    Addition of ATG to the conditioning regimen is a major determinant for outcome after transplantation with partially lymphocyte-depleted grafts from voluntary unrelated donors by SCHATTENBERG, A, VAN DER MEER, A, PREIJERS, F, SCHAAP, N, RINKES, M, VAN DER MAAZEN, R, ALLEBES, W, JOOSTEN, I, DE WITTE, Th

    Published in Bone marrow transplantation (Basingstoke) (01-06-2004)
    “…We retrospectively analysed the outcome of voluntary unrelated donor (VUD)-SCT in 56 patients after conditioning without or with ATG. All received partially…”
    Get full text
    Journal Article
  17. 17

    Outcome of T cell-depleted transplantation after conditioning with an intensified regimen in patients aged 50 years or more is comparable with that in younger patients by SCHATTENBERG, A, SCHAAP, N, PREIJERS, F, VAN DER MAAZEN, R, DE WITTE, T

    Published in Bone marrow transplantation (Basingstoke) (01-07-2000)
    “…One hundred and thirty-one patients were transplanted for AML-CR1, ALL-CR1 or CML-CP1 after conditioning with 120 mg/kg body weight cyclophosphamide and 2 x…”
    Get full text
    Journal Article
  18. 18

    Analysis of 127 Stem Cell Donations of the Regional Bone Marrow Donor Bank Europdonor Nijmegen, The Netherlands by Koopmans, E.M.J.W., Schattenberg, A., Joosten, I., Preijers, F., De Kort, W.L.A.M.

    Published in Leukemia & lymphoma (01-01-2003)
    “…In December 2000, the Bone Marrow Donor Bank Europdonor Nijmegen in the Netherlands celebrated its tenth anniversary. We describe the organisation and…”
    Get full text
    Journal Article
  19. 19

    A combination of anti-CD3 and anti-CD7 ricin A-immunotoxins for the in vivo treatment of acute graft versus host disease by VAN OOSTERHOUT, Y. V. J. M, VAN EMST, L, PREIJERS, F. W. M. B, SCHATTENBERG, A. V. M. B, TAX, W. J. M, RUITER, D. J, SPITS, H, NAGENGAST, F. M, MASEREEUW, R, EVERS, S, DE WITTE, T

    Published in Blood (15-06-2000)
    “…This study evaluated the anti-graft versus host disease (GVHD) potential of a combination of immunotoxins (IT), consisting of a murine CD3 (SPV-T3a) and CD7…”
    Get full text
    Journal Article
  20. 20

    Expansion of CD8+CD57+ T cells after allogeneic BMT is related with a low incidence of relapse and with cytomegalovirus infection by Dolstra, H, Preijers, F, Van de Wiel-van Kemenade, E, Schattenberg, A, Galama, J, de Witte, T

    Published in British journal of haematology (01-06-1995)
    “…Peripheral blood lymphocytes of 46 recipients of lymphocyte-depleted bone marrow allografts were phenotypically analysed over a period of 1 year. We…”
    Get more information
    Journal Article